About the Cancer Registry of Norway
NO
Toggle navigation
About the Cancer Registry of Norway
Search
Toggle navigation
NO
The Registries
Cancer Statistics
Data and statistics
Statistics online
Clinical registries
The Professional Council of the Quality Registers
National Colorectal Cancer Registry
Quality measurements for the Colorectal Cancer Registry
The Colorectal Cancer Registry's advisory board
Resultater fra Tykk- og endetarmskreftregisteret
Degree of coverage and data quality in the Colorectal Cancer Registry
Norwegian Breast Cancer Registry
Degree of coverage and data quality for the Breast Cancer Registry of Norway
Quality objectives for the Breast Cancer Registry of Norway
The Breast Cancer Registry's Professional Council
Resultater fra Brystkreftregisteret
Norwegian Childhood Cancer Registry
Degree of coverage and data quality in the Childhood Cancer Registry of Norway
Quality objectives for the Childhood Cancer Registry
The Norwegian Childhood Cancer Registry's advisory board
Resultater fra barnekreftregisteret
Norwegian Gynecological Cancer Registry
Coverage and data quality for the Gynecological Cancer Registry
Quality objectives for the Gynecological Cancer Registry
Gynecological Cancer Registry's Advisory Council
Resultater fra Gynekologisk kreftregister
Norwegian Lung Cancer Registry
Publiserte artikler fra Spesialregister for lungekreft
Coverage and data quality for the Lung Cancer Registry
Quality measurements for the Lung Cancer Registry of Norway
The Lung Cancer Registry's Advisory Council
Results from the Lung Cancer Registry of Norway
Norwegian Melanoma Registry
Melanoma coverage and data quality
Quality measurements for the Melanoma Register
The Melanoma Register Professional Council
Resultater fra Melanomregisteret
Norwegian Pancreatic Cancer Registry
The Advisory Council of the Pancreatic Register
Degree of coverage and data quality
Resultater
Norwegian Prostate Cancer Registry
Quality objectives for the Prostate Cancer Registry
The Prostate Cancer Registry's advisory board
Resultater fra prostatakreftregisteret
Coverage and data quality in the Prostate Cancer Registry
Norwegian registry of brain and spinal cord tumours
Fagrådet
Resultater fra Kvalitetsregister for hjerne- og ryggmargssvulster
Degree of coverage and data quality
Norwegian Registry of Lymphoid Malignancies
Degree of coverage and data quality for the Norwegian Registry for Lymphoid Malignancies
Quality measure for the Norwegian Registry for Lymphoid Malignancies
Advisory Council of the National Registry of Lymphoid Malignancies
Resultater fra Register for lymfoide maligniteter
Norwegian Registry of Oesophagus and Stomach Cancer
Degree of coverage and data quality
Academic Council
Resultater
Norwegian Sarcoma Cancer Registry
Academic Council
Degree of coverage and data quality
Quality measurements for the Sarcoma Registry
Resultater
Reporting
Electronic Notification Service
Notifiable diagnoses
Functionality in KREMT
Further development in KREMT
KREMT helpdesk
Contact persons - reminders
Development projects - reporting
Notification form for paper reporting
Reporting - pathology
NORDCAN
Research
News & Events
RNA forum
Departments and reseachers
Section for Molecular Epidemiology and Infections
The Section for Analysis and Research
Section for administration and research support
Section for Epidemiology and Prevention
Projects
Development of AI algorithms in BreastScreen Norway
Artificial intelligence in BreastScreen Norway - a randomized controlled trial
Asbestoscement and cancer risk
BADDI: Artificial intelligence in screening with standard mammography and tomosynthesis
Brain tumor among children and adolescents
Advantages and disadvantages of artificial intelligence in BreastScreen Norway
Can we apply new methods to better follow up HPV-positive women?
Cancer among Norwegian offshore workers
Receivement and use of register data from the oil companies
Instruksjonsvideo heliport
I can't get through to “postens signeringstjeneste”
I get the message "Bank ID needs to access cookies" (iPhone)
I cannot find the “sign document” button in “postens signeringstjeneste”
I get a system error message when I try to log in with my Bank-ID
I have signed the consent, but cannot get through to the questionnaire
I am not sure if my answer was delivered
I want to withdraw my consent
Chemical exposure, night shift work and cancer risk among Norwegian offshore workers
Exposure-related risks of cancer in petroleum workers
Cancer risk after benzene exposure
Cohorts of offshore workers
Common problems when logging in and signing the consent
Academic collaborators
Financial research support
Survey among offshore workers
Background and aim
Employees in the offshore group
Projects of the offshore group
Research dissemination
Collaborators and financial research support
Cancer and pregnancy
Cancer patient pathways in Norway
Cancer risk among agricultural workers
Firefighters and cancer
Annual meeting with the professional reference group
Cardiac catheterization of children with congenital heart defects
Cost and treatment for patients with lung cancer
Course of disease in bladder cancer patients
Behandling av muskelinfiltrerende blærekreft
COVID-19 and cancer in the Nordic countries
CT examination of children and the risk of cancer (EPI-CT)
Drug use and cancer
Medications and Cancer
Mapping of drugs and cancer
Prescription drugs and cutaneous melanoma
Effectiveness of tomosynthesis in breast cancer screening
EULAT Eradicate Gallbladder Cancer
Gene activity in testicular cancer
How quickly do breast cancers grow?
Sequencing HPV for biomarker discovery
Intra-patient HPV genetic variation
HPV genomic workshop
HPV-related research
Om studien
Langtidseffekt av screening mot livmorhalskreft
Personalised cervical cancer screening
Regionale forskjeller i livmorhalskreft i Norge
Tidlig vaksinasjonseffekt: kjønnsvortetrender i Norge
Livmorhalskreft blant unge kvinner
Can we apply new methods to better follow up HPV-positive women?
Self-collected specimens in the fight against cervical cancer
Sylinderepitelforandringer i livmorhalsen og risiko for livmorhalskreft
Uønskede svangerskapsutfall etter behandling av forstadier til livmorhalskreft
Prognostiske markører for differensiering av kvinner med høy og lav risiko for utvikling av livmorhalskreft
Celleprøvetaking fra livmorhalsen (cervix) - er det så vanskelig?
Adenocarsinoma in situ i cytologisk prøve skal behandles
Fatal livmorhalskreft opp mot screeningdeltakelse og alder hos norske kvinner
Biomarkers for HPV-related cancers
Effects of HPV vaccination in Norway
EQUALSCREEN – INCREASED ATTENDANCE AND REDUSED INEQUITY IN CERVICAL CANCER SCREENING
Fight HPV and Cervical Cancer
Prevalence of human papillomavirus (HPV) among the population
Forekomst av HPV-typer blant kvinner med forstadier og livmorhalskreft
HPV-vaksinering og screening blant kvinner født 1975-1996
Kvinners livsstil og helse - forskning på livsstil, virus og kreft
ImmigrantScreen
Impact of vitamin D and obesity on bladder cancer; Risk and survival
Innovative commitment to action against cancer (iPAAC)
INSPIRE - information about drug cancer treatment
INSPIRE:lung cancer
INSPIRE: Breast cancer
Publications from INSPIRE
INSPIRE:kidney cancer
JanusRNA - identification of early cancer biomarkers
miRNA signaturer i pasienter med kreft i tykktarm, bryst og lunge
Biomarkers of Cancer: Biocomputional analysis of data from population-based biobanks and health registries
Bakgrunn og formål
Data
Publikasjoner
Prosjektgruppen
Samarbeidspartnere og finansiering
JanusRNA delprosjekter
JanusRNA - identification of early cancer biomarkers
Largyngeal Papillomatosis / Recurrent Respiratory Papillomatosis (RRP)
Largyngeal papillomatose / Recurrent Respiratory Papillomatosis (RRP)
Deltakerinformasjon
Bli kjent med prosjektgruppen
Finansiering og samarbeid
Forskningsformidling
Background and objective
Participant information
Meet the research group
Financing and collaborations
Publications
Lifestyle changes and future health
Long-term effects following treatment of screen-detected versus symptomatic breast cancer
LTFU: Long-term follow up of subjects participating in the clinical trials of the HPV-vaccine
Blodprøvetaking i "Utvidet langtidsoppfølging av deltakere i studien med vaksine mot livmorhalskreft" LTFU studien
Financing
Collaborations
LTFU V501: Extended Long-Term Follow-Up of Women Participating in the Cervical Cancer Vaccine Study (FUTURE II)
LTFU V503: Long-Term Follow-Up of Women Participating in the Phase III Clinical Trial with the 9-valent HPV Vaccine
Publications
Media and dissemination
Participant information V501
Participant information V503
Long-Term Follow-Up (LTFU) of Nordic Women Participating in Early Studies of Cervical Cancer Vaccines
Research projects
Participant information
Research group
Financing and collaborations
Research dissemination
The microbiome as a colorectal cancer screening biomarker (CRCbiome)
Sammenheng mellom bearbeidet mat og tarmkreft
Mikrobiella biomarkører - NORCCAP
Deltakerinformasjon CRCbiome
Masterprosjekter
New cancer treatment and survival
Immunotherapy and targeted therapy of advanced non-small cell lung carcinoma
New cancer treatment and survival: prostate cancer
Ny kreftbehandling og overlevelse: føflekkreft
Nordpred: Prediction of cancer incidence in the Nordic countries up to the year 2020
Nordpred software package
A randomized study on colorectal cancer screening (NORCCAP)
NORCCAP - Ph.D theses
NORCCAP - publications
Rådgivingsgruppe NORCCAP-biobank
Using the OMOP data model
FLORENCE: Federated Learning on Cancer Data
FLORENCE: føderert læring på kreftdata
BlueBerry
Andre OMOP prosjekter
Blueberry
Other OMOP projects
Dissemination
Collaborators
AI solution for use in cancer operations under the EU program Interreg ØKS
Samarbeidspartnere
Using the OMOP datamodel
Research projects
OMOP EHDEN project: CRN maps its core variables to OMOP CDM
Bruk av datamodellen OMOP
Forskningsprosjekter
Forskningsformidling
Patient reported outcomes after treatment for colorectal cancer – A prospective nationwide study from The Norwegian Colorectal Cancer Registry
Personalizing colorectal cancer screening by lifestyle
Physical activity, fitness and cancer
Prescribed drugs and cutaneous melanoma
Research on environmental toxins and cancer
SARS-CoV-2 in cancer patients
Stress management after breast cancer (SEB)
For deltakere: Stressmestring etter brystkreft
Spørsmål og svar
Terminated projects
Hva vil undersøkelsen omfatte?
Hva skal gjøres i prosjektet, og er det laget en tidsplan?
Vil det bli gjort medisinske undersøkelser på de som ikke har konstatert kreft i dag, naboer eller tidligere raffineriansatte?
Hva bør man gjøre dersom man er bekymret for helsen (kreftrisiko)?
Hvorfor er personer som ikke er naboer eller tidligere raffineriansatte, men som har eller har hatt arbeidsplass i nærheten av raffineriet, ikke med i undersøkelsen?
Er sektorene for dominerende vindretninger og antatt nedslagsfelt, slik de har vært presentert i media riktig?
Vil undersøkelsen kun basere seg på tall og statistisk materiale?
Kommer naboer til å bli invitert til å delta i undersøkelsen, f.eks. ved intervju? Når vil det i så fall skje?
Hvem sitter i ressursgruppa?
Ser man i denne undersøkelsen etter alle, eller spesifikke krefttyper, og i så fall hvilke krefttyper ser man etter?
Hvilke krefttyper er dette (se spørsmål over)?
Hvordan kan man skille mellom kreft pga arv, gener, livsstil og annen eksponering, og kreft pga raffineriet?
Hvilke konklusjoner har man fra andre undersøkelser knyttet til sammenhengen mellom kreft og raffineri-virksomhet?
Status per 31. oktober 2008
Ofte stilte spørsmål
Information for participants in the project "Cancer risk among nurses"
Social inequality and HPV vaccination
SVEIP: Effect of School based HPV-vaccination in the population
Does Gardasil cause birth defects?
Sola-prosjektet (Fullført 2009)
What prevents women from taking cervical pap smear?
Improving the mass screening for cervical cancer
Why do some precancerous lesions develop into cervical cancer?
Cancer risk of preinvasive adenocarcinoma
Penile cancer
Cancer risk among nurses
Overdiagnosis and underdiagnosis in BreastScreen Norway
How likely are benign breast disease and premalignant lesions to progress to invasive breast cancer?
Breast compression in BreastScreen Norway
Testicular cancer and heredity
The impact of obesity and circulating small RNA in the development of endometrial cancer
Tomosynthesis – the future screening tool for breast cancer?
Vitamin D and cancer prognosis
Vitamin D, obesity and cutaneous malignant melanoma
Scientific publications
List of publications 2016
Under 30 forfattere
Over 30 forfattere
List of publications 2015
Artikler under 30 forfattere
Artikler over 30 forfattere
List of publications 2014
List of publications 2013
List of publications 2012
List of publications 2011
List of publications 2010
List of publications 2009
List of Publications 2008
Published articles 2017
First and/or last author
All published articles 2017
Published articles 2018
First and/or last author
All published articles
Published articles 2019
first and/or last author
All published articles
Published articles 2020
All published articles
First and/or last author
Published articles 2021
Published articles 2022
Published articles 2023
Janus Serum Bank
About Janus serum bank
Articles of association
For participants
For researchers
Quality assurance
How to apply for biological material and data from the Janus serum bank
Terms and conditions for use of biological material and data from the Janus serum bank
The Janus material
Research activities
Published articles
Screening
About the Screening Programmes
BreastScreen Norway
Breast Cancer Screening Programme
About the programme
Ofte Stilte Spørsmål
Samtykke
The screening mammogram
Benefits and harms
Diskusjon om nytteverdi
Om beregninger for brystkreftdødelighet og overdiagnostikk
More information about advantages and disadvantages of breast cancer screening
EU-TOPIA
Information resources in BreastScreen Norway
Breast centres
Translations
Information in Polish
Information in Urdu
Information in English
Information in Arabic
Information in Somali
Northern Sami
Ukrainian
Why the age group 50-69 years?
European guidelines
Organization
Helseforetak i Mammografiprogrammet
Research in BreastScreen Norway
Quality assurance and quality improvement
BERM: Bedre Radiografi i Mammografiprogrammet
Film: How mammography takes place
Cervical Cancer Screening in Norway
Letters
Self-sampling in Cervical Screen Norway
Frequently asked questions
Hva er konisering?
Hva er HPV hjemmetest?
Slik tar du livmorhalsprøven
How often should I take a cervical test?
Symptoms
Hva er livmorhalskreft?
Informasjon om celleforandringer
The PAP test
HPV Vaccine
HPV
Benefits and harms of screening
Primary HPV test - now also for women under 34
Information for women about HPV test in CervicalScreen Norway
I'm HPV positive - now what?
Status for implementering av HPV-test
Reservation
Nå kan Livmorhalsprogrammet dele prøvehistorikk
Vaccine
Cervical Cancer Screening Programme
Translations
Informasjon på somalisk
Litausk
Informasjon på urdu
Information in Polish
Oversettelser til engelsk/English translations
Informasjon på ukrainsk
ColorectalScreen Norway
Invited to screening?
What is screening?
Pros and cons
When will the screening program be available for you?
Cancer prevention
What is Colorectal cancer ?
Research
Privacy
Information in the program
Employees
Vacant positions
Media
Strategy
Data and statistics
Cancer in Norway
Publications
Personvern
Key figures on cancer
Cancers
About the Cancer Registry of Norway
Search
Toggle navigation
NO
The Registries
Cancer Statistics
Data and statistics
Clinical registries
Reporting
NORDCAN
Research
News & Events
Departments and reseachers
Projects
Scientific publications
Janus Serum Bank
Screening
About the national screening programmes
BreastScreen Norway
CervicalScreen Norway
ColorectalScreen Norway
Employees
Data and statistics
Key figures on cancer
Vacant positions
Cancer in Norway
Cancers
Media
Publications
Strategy
Personvern
Screening
/
Screening
About the Screening Programmes
BreastScreen Norway
Cervical Cancer Screening Programme
ColorectalScreen Norway
CervicalScreen Norway
/
Cervical Cancer Screening Programme
Letters
Hjemmetest
FAQ
Benefits and harms of screening
Primary HPV test - now also for women under 34
Reservation
Vaccine
Cervical Cancer Screening Programme
Translations
Frequently asked questions
/
FAQ
How often should I take a test?
Symptoms
The PAP test
HPV
Vaccine
The PAP test
The PAP test
